A1.5M赠款资助金融情报室利用现有药物研究治疗难以治疗的癌症,这预示着早期的希望。 A $1.5M grant funds FIU research using existing drugs to treat hard-to-treat cancers, showing early promise.

泰勒·特伦特基金会提供150万美元的赠款,资助佛罗里达国际大学研究如何将现有药物——如抗生素和抗芬加素——重新用于治疗难以治愈的癌症。 A $1.5 million grant from the Tyler Trent Foundation is funding Florida International University research into repurposing safe, existing drugs—like antibiotics and antifungals—for hard-to-treat cancers. 该方法直接对病人的活肿瘤细胞进行数百种非癌症药物测试,以找到有效的组合,为传统化疗提供更快捷、毒性更低的替代品。 The approach tests hundreds of non-cancer drugs directly on patients’ living tumor cells to find effective combinations, offering a faster, less toxic alternative to traditional chemotherapy. 早期结果显示反应有所改进,特别是在有更多的药物接受测试时。 Early results show improved responses, especially when more drugs are tested. 这项工作由Diana Azzam博士领导,目的是通过使用医生已经批准和熟悉的药物,加快获得治疗的机会。 The work, led by Dr. Diana Azzam, aims to accelerate treatment access by using medications already approved and familiar to doctors. 该基金会是为纪念泰勒·特伦特创立的,他是一位年轻的骨科肿瘤患者,他的倡导和乐观精神继续激励癌症研究和病人护理工作。 The foundation was created in memory of Tyler Trent, a young osteosarcoma patient whose advocacy and optimism continue to inspire cancer research and patient care efforts.